Clinical Scorecard: Evaluation of PET Imaging Agents for Localizing Parathyroid Glands: A Comprehensive Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Primary hyperparathyroidism (pHPT)
Key Mechanisms
Elevated serum calcium and inappropriately elevated parathyroid hormone due to parathyroid adenoma(s)
Target Population
Adults ≥17 years with biochemical non-familial pHPT
Care Setting
Surgical setting with preoperative imaging for minimally invasive parathyroidectomy
Key Highlights
pHPT is commonly caused by a single parathyroid adenoma (75–85%), with multiple adenomas or carcinoma less frequent.
99Tc-sestamibi SPECT-CT is first-line imaging but has limited sensitivity (63–84%), leading to equivocal cases.
PET imaging offers higher spatial and temporal resolution; 11C-Methionine (11C-MET) is the most extensively studied PET tracer for parathyroid localization.
Guideline-Based Recommendations
Diagnosis
Biochemical diagnosis with elevated serum calcium and inappropriately elevated PTH.
Use of imaging to localize pathological gland(s) prior to surgery, especially for minimally invasive parathyroidectomy.
Management
Surgical exploration recommended for symptomatic patients, those with significant renal or bone manifestations, or age <50 years.
Minimally invasive parathyroidectomy preferred when accurate preoperative localization is available.
Monitoring & Follow-up
Post-surgical pathological confirmation remains the gold standard for diagnosis.
Imaging follow-up guided by clinical and biochemical status.
Risks
Limitations of imaging sensitivity may lead to equivocal localization and impact surgical planning.
Not all PET tracers are suitable due to factors like tracer half-life and specificity.
Patient & Prescribing Data
Adults with biochemical diagnosis of primary hyperparathyroidism undergoing preoperative localization imaging
11C-Methionine PET shows promise with pooled sensitivity and positive predictive value for localizing pathological parathyroid glands, potentially improving surgical outcomes.
Clinical Best Practices
Employ biochemical testing to confirm pHPT before imaging.
Use 99Tc-sestamibi SPECT-CT as first-line imaging modality.
Consider PET imaging, particularly with 11C-Methionine, in cases with equivocal or negative first-line imaging.
Ensure surgical planning incorporates imaging findings to enable minimally invasive parathyroidectomy when feasible.
Assess study quality and imaging protocols carefully to interpret PET results accurately.
by Wouter P. Kluijfhout, Jesse D. Pasternak, Frederick Thurston Drake, Toni Beninato, Jessica E. Gosnell, Wen T. Shen, Quan-Yang Duh, Isabel E. Allen, Menno R. Vriens, Bart de Keizer, Miguel H. Pampaloni, Insoo Suh
Researchers at Florida International University (FIU), working in collaboration with Baptist Health South Florida, are combining a digital stethoscope with artificial intelligence (AI) and advanced sound analysis to better detect subtle signs of heart disease long before symptoms appear.
